The present invention features methods and compositions for inhibiting
amyloidogenic protein toxicity, inhibiting formation of an amyloidogenic
protein deposit and/or treating amyloidogenic diseases by administering a
pharmaceutically effective amount of one or more agents that bind an
integrin or an integrin subunit.